Product Description
Overview
If not diagnosed and treated within the newborn period, it can lead to diarrhea, dehydration, jaundice, hepatic failure, hypoglycemia, cataracts, developmental retardation, and death within a few weeks. Treatment of the disease consists of withdrawal of all foods containing lactose and galactose from the diet.
GSP Neonatal GALT - the first automated GALT assay
The GSP Neonatal GALT assay is used as an aid in screening newborns for classic galactosemia caused by GALT deficiency using the GSP™ instrument.
Faster assay - incubation time now only 2 h
Improved precision compared to manual assays
Provides results in today’s preferred unit, U/dL
Contains reagents for 1152 tests (12 plates), clear microplates should be ordered separately in a bulk pack of 50
Floating disks control Application-Newborn Screening
Brand-GSP®
Detection Modality-Enzymatic
Disorders-Galactosemia
Instrument Compatibility-GSP
Quantity-1152 tests
Regulatory Status-CE-IVD marked
Sample Type-Dried blood spots
Technology-Enzymatic
Unit Size-12 plates
Order Guidelines
1. Price & Stock Available on Request. Click to send email to: service@iright.com
2. Please DO NOT make payment before confirmation.
3. Minimum order value of $1,000 USD required.
Collaboration
Tony Tang
Email: Tony.Tang@iright.com
Mobile/WhatsApp/Wechat: +86-17717886924